Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.76 Billion CNY | -59.16% |
| 2022 | 6.78 Billion CNY | -3.85% |
| 2021 | 7.05 Billion CNY | 15.31% |
| 2020 | 6.11 Billion CNY | 6.54% |
| 2019 | 5.74 Billion CNY | 28.56% |
| 2018 | 4.46 Billion CNY | 179.87% |
| 2017 | 1.59 Billion CNY | 30.1% |
| 2016 | 1.22 Billion CNY | 459.67% |
| 2015 | -340.95 Million CNY | -1195.14% |
| 2014 | -26.32 Million CNY | -106.39% |
| 2013 | 412.15 Million CNY | 213.22% |
| 2012 | -364.03 Million CNY | -278.17% |
| 2011 | 204.31 Million CNY | 251.71% |
| 2010 | -134.67 Million CNY | -80.47% |
| 2009 | -74.62 Million CNY | -434.56% |
| 2008 | 22.3 Million CNY | -79.75% |
| 2007 | 110.17 Million CNY | 265.32% |
| 2006 | -66.64 Million CNY | -11.71% |
| 2005 | -59.65 Million CNY | 21.16% |
| 2004 | -75.67 Million CNY | -206.78% |
| 2003 | 70.86 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 6.04 Billion CNY | 118.32% |
| 2024 Q2 | 6.04 Billion CNY | 1.13% |
| 2023 Q3 | 5.16 Billion CNY | -4.22% |
| 2023 Q2 | 5.39 Billion CNY | 0.23% |
| 2023 Q1 | 5.38 Billion CNY | -20.63% |
| 2023 FY | 2.76 Billion CNY | -59.16% |
| 2023 Q4 | 2.76 Billion CNY | -46.4% |
| 2022 Q3 | 6.76 Billion CNY | 16.36% |
| 2022 Q2 | 5.81 Billion CNY | 0.27% |
| 2022 Q1 | 5.79 Billion CNY | -17.79% |
| 2022 FY | 6.78 Billion CNY | -3.85% |
| 2022 Q4 | 6.78 Billion CNY | 0.23% |
| 2021 Q3 | 7.02 Billion CNY | 77.38% |
| 2021 Q4 | 7.05 Billion CNY | 0.32% |
| 2021 Q1 | 3.95 Billion CNY | -35.35% |
| 2021 Q2 | 3.96 Billion CNY | 0.23% |
| 2021 FY | 7.05 Billion CNY | 15.31% |
| 2020 Q4 | 6.11 Billion CNY | 0.21% |
| 2020 Q1 | 5.19 Billion CNY | -9.46% |
| 2020 FY | 6.11 Billion CNY | 6.54% |
| 2020 Q3 | 6.1 Billion CNY | 17.1% |
| 2020 Q2 | 5.21 Billion CNY | 0.28% |
| 2019 Q3 | 6.2 Billion CNY | 29.52% |
| 2019 FY | 5.74 Billion CNY | 28.56% |
| 2019 Q1 | 4.77 Billion CNY | 6.93% |
| 2019 Q2 | 4.79 Billion CNY | 0.38% |
| 2019 Q4 | 5.74 Billion CNY | -7.53% |
| 2018 Q2 | 4.14 Billion CNY | 0.0% |
| 2018 Q1 | 4.14 Billion CNY | 159.84% |
| 2018 Q3 | 4.46 Billion CNY | 7.7% |
| 2018 Q4 | 4.46 Billion CNY | 0.0% |
| 2018 FY | 4.46 Billion CNY | 179.87% |
| 2017 Q2 | 1.75 Billion CNY | 0.01% |
| 2017 FY | 1.59 Billion CNY | 30.1% |
| 2017 Q4 | 1.59 Billion CNY | 0.01% |
| 2017 Q3 | 1.59 Billion CNY | -8.96% |
| 2017 Q1 | 1.75 Billion CNY | 42.88% |
| 2016 Q2 | -918.08 Million CNY | 0.02% |
| 2016 Q3 | 1.22 Billion CNY | 233.56% |
| 2016 Q4 | 1.22 Billion CNY | 0.01% |
| 2016 FY | 1.22 Billion CNY | 459.67% |
| 2016 Q1 | -918.23 Million CNY | -169.31% |
| 2015 Q4 | -340.95 Million CNY | 0.04% |
| 2015 Q3 | -341.09 Million CNY | 28.02% |
| 2015 Q2 | -473.88 Million CNY | 0.03% |
| 2015 Q1 | -474.02 Million CNY | -1700.58% |
| 2015 FY | -340.95 Million CNY | -1195.14% |
| 2014 FY | -26.32 Million CNY | -106.39% |
| 2014 Q2 | 711.48 Million CNY | 0.02% |
| 2014 Q1 | 711.33 Million CNY | 72.59% |
| 2014 Q3 | 153.53 Million CNY | -78.42% |
| 2014 Q4 | -26.32 Million CNY | -117.15% |
| 2013 Q1 | 364.03 Million CNY | 0.0% |
| 2013 FY | 412.15 Million CNY | 213.22% |
| 2013 Q4 | 412.15 Million CNY | 0.03% |
| 2013 Q3 | 412.01 Million CNY | 0.0% |
| 2012 Q1 | 216.33 Million CNY | 5.88% |
| 2012 Q2 | 201.92 Million CNY | -6.66% |
| 2012 FY | -364.03 Million CNY | -278.17% |
| 2011 Q2 | -96.81 Million CNY | 37.87% |
| 2011 FY | 204.31 Million CNY | 251.71% |
| 2011 Q3 | 129.06 Million CNY | 233.31% |
| 2011 Q4 | 204.31 Million CNY | 58.3% |
| 2011 Q1 | -155.84 Million CNY | -15.71% |
| 2010 Q1 | -101.38 Million CNY | -35.86% |
| 2010 FY | -134.67 Million CNY | -80.47% |
| 2010 Q4 | -134.67 Million CNY | 15.77% |
| 2010 Q3 | -159.89 Million CNY | 1.94% |
| 2010 Q2 | -163.04 Million CNY | -60.83% |
| 2009 FY | -74.62 Million CNY | -434.56% |
| 2009 Q4 | -74.62 Million CNY | 0.0% |
| 2008 FY | 22.3 Million CNY | -79.75% |
| 2007 FY | 110.17 Million CNY | 265.32% |
| 2006 FY | -66.64 Million CNY | -11.71% |
| 2005 FY | -59.65 Million CNY | 21.16% |
| 2004 FY | -75.67 Million CNY | -206.78% |
| 2003 FY | 70.86 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | -12.45 Billion HKD | 122.241% |